1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Technology Outlook
3.3. Application Outlook
3.4. End User Outlook
3.5. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges


6. United States Transcriptomics Technologies Market, By Technology
6.1. Introduction
6.2. Gene Regulation Technologies
6.3. Microarray
6.4. Next Generation Sequencing
6.5. PCR


7. United States Transcriptomics Technologies Market, By Application
7.1. Introduction
7.2. Bioinformatics
7.3. Clinical Diagnostics
7.4. Comparative Transcriptomics
7.5. Drug Discovery & Research


8. United States Transcriptomics Technologies Market, By End User
8.1. Introduction
8.2. Academic Research
8.3. Pharmaceutical & Biotech Companies


9. 360iResearch Competitive Strategic Window
9.1. Introduction
9.2. 360iResearch Competitive Strategic Window, by Technology
9.3. 360iResearch Competitive Strategic Window, by Application
9.4. 360iResearch Competitive Strategic Window, by End User


10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. 360iResearch Market Ranking Analysis
10.3. 360iResearch Market Share Analysis
10.4. 360iResearch Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion


11. Company Usability Profiles
11.1. Fluidigm Corporation
11.2. Life Technologies Corporation
11.3. Qiagen N. V.
11.4. Sigma Aldrich Corporation
11.5. Thermo Fisher Scientific


12. Appendix
12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details